Restricted accessRetractionFirst published online 2021-11
Retraction of: Long-Term Maintenance of Undifferentiated Human Embryonic and Induced Pluripotent Stem Cells in Suspension (doi.org/10.1089/scd.2010.0517)
VosoughM, OmidiniaE, KadivarM, ShokrgozarM-A, PournasrB, AghdamiN, and HBaharvand. (2013). Generation of functional hepatocyte-like cells from human pluripotent stem cells in a scalable suspension culture. Stem Cells Dev, 22:2693-2705.
2.
AbbasalizadehS, LarijaniMR, SamadianA, and HBaharvand. (2012). Bioprocess development for mass production of size-controlled human pluripotent stem cell aggregates in stirred suspension bioreactor. Tissue Eng Part C Methods, 18:831-851.
3.
FarzanehZ, NajaraslM, AbbasalizadehS, VosoughM, and HBaharvand. (2017). Developing a cost-effective and scalable production of human hepatic competent endoderm from size-controlled pluripotent stem cell aggregates. Stem Cells Dev, 27,(4)::262-274.
4.
HeidariyanZ, GhanianMH, AshjariM, FarzanehZ, NajaraslM, LarijaniMR, PiryaeiA, VosoughM, and HBaharvan. (2018). Efficient and cost-effective generation of hepatocyte-like cells through microparticle-mediated delivery of growth factors in a 3D culture of human pluripotent stem cells. Biomaterials, 159:174-188.
FonoudiH, AnsariH, AbbasalizadehS, LarijaniMR, KianiS, HashemizadehS, ZarchiAS, BosmanA, BlueGM, PahlavanS, PerryM, OrrY, MayorchakY, VandenbergJ, TalkhabiM, WinlawDS, HarveyRP, AghdamiN, and HBaharvand. (2015). A universal and robust integrated platform for the scalable production of human cardiomyocytes from pluripotent stem cells. Stem Cells Transl Med, 4,(12)::1482-94.
7.
VahdatS, PahlavanS, MahmoudiE, BarekatM, AnsariH, BakhshandehB, AghdamiN, and HBaharvand. (2019). Expansion of human pluripotent stem cell-derived early cardiovascular progenitor cells by a cocktail of signaling factors. Sci Rep, 9(1):16006.
